{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:12:19Z","timestamp":1790709139171,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009660","name":"LSHTM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009660","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The WHO recommends that individuals exposed to persons with multidrug resistant tuberculosis (MDRTB) should be screened for active TB and followed up for 2 years to detect and treat secondary cases early. Resource prioritisation means this is rarely undertaken and where it is performed it\u2019s usually using a paper-based record, without collation of data. Electronic data collection into a web-based registry offers the opportunity for simplified and systematic TB contact surveillance with automatic synthesis of data at local, regional and national level. This pilot study was designed to explore the feasibility of usage of a novel e-registry tool and explore obstacles and facilitating factors to implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In parallel with their paper records, seven dispensaries in Ulaanbaatar, Mongolia collected standardized data electronically using Open Data Kit (ODK). Patients with MDRTB and their contacts were recruited during a single clinic visit. Staff and patients were interviewed to gain insights into acceptability and to identify areas for improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventy household contacts of 32 MDR-TB index patients were recruited. 7\/70 contacts (10%) traced had active TB at the time they were recruited to the e-registry.<\/jats:p>\n                    <jats:p>Paper registry satisfaction was low; 88% of staff preferred the e-registry as it was perceived as faster and more secure. Patients and their contacts were generally supportive of the e-registry; however, a significant minority 10\/42 (24%) of index cases who were invited, declined to participate in the e-registry, with data security cited as their top concern.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>E-registries are a promising tool for MDRTB contact tracing, but their acceptability amongst patients should not be taken for granted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12911-020-01204-z","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T08:03:47Z","timestamp":1597219427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["An e-registry for household contacts exposed to multidrug resistant TB in Mongolia"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1853-9330","authenticated-orcid":false,"given":"Kush","family":"Naker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Gaskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munhjargal","family":"Dorjravdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naranzul","family":"Dambaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrissy H.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A. J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"1204_CR1","unstructured":"WHO. Guidelines on the management of latent tuberculosis infection. Geneva: WHO; 2015."},{"key":"1204_CR2","unstructured":"WHO Guidelines Review Committee. WHO treatment guidelines for drug-resistant tuberculosis 2016 update. Geneva: WHO; 2016."},{"key":"1204_CR3","unstructured":"WHO. The Stop TB Strategy. Geneva: WHO; 2006."},{"key":"1204_CR4","unstructured":"WHO. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: WHO; 2006."},{"key":"1204_CR5","unstructured":"WHO. Recommendations for investigating contacts of persons with infectious tuberculosis in low-and middle-income countries. Geneva: WHO; 2012."},{"key":"1204_CR6","unstructured":"WHO. End TB Strategy. Geneva: WHO; 2015."},{"key":"1204_CR7","unstructured":"WHO. Global Tuberculosis Report. Geneva: WHO; 2018."},{"issue":"12","key":"1204_CR8","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/cid\/cix208","volume":"64","author":"SM Marks","year":"2017","unstructured":"Marks SM, Mase SR, Bamrah MS. Systematic review, meta-analysis, and cost-effectiveness of treatment of latent tuberculosis to reduce progression to multidrug-resistant tuberculosis. Clin Infect Dis. 2017;64(12):1670\u20137.","journal-title":"Clin Infect Dis"},{"key":"1204_CR9","first-page":"1","volume":"1","author":"JA Seddon","year":"2015","unstructured":"Seddon JA, et al. Post-Exposure Management of Multidrug-Resistant Tuberculosis Contacts: Evidence-Based Recommendations. Policy Brief. 2015;1. Dubai:1.","journal-title":"Policy Brief"},{"key":"1204_CR10","unstructured":"ISRCTN registry [Internet]. London: BMC. [2005] ISRCTN92634082, Tuberculosis child multidrug-resistant preventive therapy: TB CHAMP trial; 2016. Available from: http:\/\/www.isrctn.com\/ISRCTN92634082. [cited 2020 Feb 25]."},{"key":"1204_CR11","unstructured":"Australian New Zealand Clinical Trials Registry [Internet]: Sydney (NSW): NHMRC Clinical Trials Centre, University of Sydney (Australia); 2016. Identifier ACTRN12616000215426. The V-QUIN MDR TRIAL: A randomized controlled trial of six months of daily levofloxacin for the prevention of tuberculosis among household contacts of patients with multi-drug resistant tuberculosis; 2016.  Available from https:\/\/anzctr.org.au\/ACTRN12616000215426.aspx. [cited 2020 Feb 25]."},{"key":"#cr-split#-1204_CR12.1","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29. Indentifier NCT03568383, Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients (PHOENIx MDR-TB)"},{"key":"#cr-split#-1204_CR12.2","unstructured":"2018. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03568383. [cited 2020 Feb 25]."},{"issue":"1","key":"1204_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1183\/09031936.00070812","volume":"41","author":"GJ Fox","year":"2013","unstructured":"Fox GJ, et al. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2013;41(1):140\u201356.","journal-title":"Eur Respir J"},{"issue":"3","key":"1204_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/cid\/cit643","volume":"58","author":"NS Shah","year":"2014","unstructured":"Shah NS, et al. Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic Review and Meta-analysis. Clin Infect Dis. 2014;58(3):381\u201391.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1204_CR15","doi-asserted-by":"publisher","first-page":"1701044","DOI":"10.1183\/13993003.01044-2017","volume":"50","author":"C Kodama","year":"2017","unstructured":"Kodama C, et al. Mycobacterium tuberculosis transmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis. Eur Respir J. 2017;50(4):1701044.","journal-title":"Eur Respir J"},{"issue":"July 2014","key":"1204_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5588\/ijtld.14.0512","volume":"19","author":"E Fair","year":"2015","unstructured":"Fair E, et al. Tuberculosis contact investigation in low- and middle-income countries : standardized definitions and indicators. Int J Tuberc Lung Dis. 2015;19(July 2014):269\u201372.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1204_CR17","volume-title":"Definitions and reporting framework for tuberculosis \u2013 2013 revision","author":"WHO","year":"2014","unstructured":"WHO. Definitions and reporting framework for tuberculosis \u2013 2013 revision. 2014."},{"issue":"1","key":"1204_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12916-016-0610-x","volume":"14","author":"DAJ Moore","year":"2016","unstructured":"Moore DAJ. What can we offer to 3 million MDRTB household contacts in 2016? BMC Med. 2016;14(1):64.","journal-title":"BMC Med"},{"issue":"3 SUPPL. 1","key":"1204_CR19","first-page":"8","volume":"12","author":"P Nadol","year":"2008","unstructured":"Nadol P, et al. Electronic tuberculosis surveillance systems: A tool for managing today\u2019s TB programs. Int J Tuberc Lung Dis. 2008;12(3 SUPPL. 1):8\u201316.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1204_CR20","doi-asserted-by":"publisher","unstructured":"Konduri N, Sawyer K, Nizova N. User experience analysis of e-TB Manager, a nationwide electronic tuberculosis recording and reporting system in Ukraine. ERJ Open Res 2017;3:00002-2017 [https:\/\/doi.org\/10.1183\/23120541.00002-2017].","DOI":"10.1183\/23120541.00002-2017"},{"issue":"10","key":"1204_CR21","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/10810730.2016.1222035","volume":"21","author":"YP Ha","year":"2016","unstructured":"Ha YP, et al. Evaluation of a mobile health approach to tuberculosis contact tracing in Botswana. J Health Commun. 2016;21(10):1115\u201321.","journal-title":"J Health Commun"},{"key":"1204_CR22","doi-asserted-by":"publisher","first-page":"11559","DOI":"10.3390\/ijerph111111559","volume":"11","author":"J Brinkel","year":"2014","unstructured":"Brinkel J, et al. Mobile Phone-Based mHealth Approaches for Public Health Surveillance in Sub-Saharan Africa : A Systematic Review. Int J Environ Res Public Health. 2014;11:11559\u201382.","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"1204_CR23","first-page":"737","volume":"4","author":"L Alpers","year":"2000","unstructured":"Alpers L, et al. Validation of the surveillance system for tuberculosis in Botswana. Int J Tuberc Lung Dis. 2000;4(8):737\u201343.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"1204_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.tube.2013.05.001","volume":"93","author":"C Bristow","year":"2013","unstructured":"Bristow C, et al. Lack of patient registration in the electronic TB register for sputum smear-positive patients in KwaZulu-Natal, South Africa. Tuberculosis (Edinb). 2013;93(5):567\u20138.","journal-title":"Tuberculosis (Edinb)"},{"key":"1204_CR25","volume-title":"WHO Tuberculosis burden estimates dataset","author":"WHO","year":"2017","unstructured":"WHO. WHO Tuberculosis burden estimates dataset. 2017 [cited 2020 Feb 8]. Available from: https:\/\/www.who.int\/tb\/country\/data\/download\/en\/."},{"key":"1204_CR26","volume-title":"Personal communication","author":"NCCD Mongolia","year":"2017","unstructured":"NCCD Mongolia. Personal communication. 2017."},{"key":"1204_CR27","unstructured":"Green J, Thorogood N. Qualitative Methods for Health Research. 3rd ed. London: SAGE Publications Ltd; 2014."},{"key":"1204_CR28","unstructured":"Mongolian Ministry of Health. Manual on management of tuberculosis care and service - 1st Annex of the Ministerial order of the Ministry of Health N319. Ulaanbaatar: Mongolian Ministry of Health; 2014."},{"key":"1204_CR29","unstructured":"WHO. Health statistics and information systems. [cited 2020 Feb 8]. Available from: https:\/\/www.who.int\/healthinfo\/tools_data_analysis_routine_facility\/en\/."},{"key":"1204_CR30","volume-title":"DHIS2: Safeguarding historical TB data","author":"WHO","year":"2017","unstructured":"WHO. DHIS2: Safeguarding historical TB data. 2017 [cited 2020 Feb 8]. Available from: https:\/\/tbhistoric.org\/dhis-web-commons\/security\/login.action."}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-020-01204-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-020-01204-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-020-01204-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T19:30:11Z","timestamp":1628710211000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-020-01204-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1204"],"URL":"https:\/\/doi.org\/10.1186\/s12911-020-01204-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-16123\/v1","asserted-by":"object"}]},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"25 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Mongolian Ministry of Health research ethics committee (Ref: 18) and the London School of Hygiene and Tropical Medicine (Ref: 13882).All participants (and parent or guardian in the case of children under 18) were provided written information about the research and gave written informed consent to participate, as well as having anonymised data published and shared for the purposes of research. Patients who chose not to participate in the e-registry were also invited to complete an optional anonymous feedback form to explain their reasoning, and this was deemed acceptable by both ethics committees above.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of individual persons anonymised data was obtained from each participant (and from their parent or guardian in the chase of children under 18) alongside consent to participate in the e-registry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}